Search Results

There are 2450 results for: content related to: Bioavailability of a silybin–phosphatidylcholine complex in dogs

  1. Silymarin Ascending Multiple Oral Dosing Phase I Study in Noncirrhotic Patients With Chronic Hepatitis C

    The Journal of Clinical Pharmacology

    Volume 50, Issue 4, April 2010, Pages: 434–449, Dr Roy L. Hawke, Dr Sarah J. Schrieber, Dr Tedi A. Soule, Dr Zhiming Wen, Dr Philip C. Smith, Dr K. Rajender Reddy, Dr Abdus S. Wahed, Dr Steven H. Belle, Dr Nezam H. Afdhal, Dr Victor J. Navarro, Dr Josh Berman, Dr Qi-Ying Liu, Dr Edward Doo, Dr Michael W. Fried and The SyNCH Trial Group

    Version of Record online : 7 MAR 2013, DOI: 10.1177/0091270009347475

  2. You have free access to this content
    Hepatoprotective and antiviral functions of silymarin components in hepatitis C virus infection

    Hepatology

    Volume 57, Issue 3, March 2013, Pages: 1262–1271, Stephen J. Polyak, Peter Ferenci and Jean-Michel Pawlotsky

    Version of Record online : 28 FEB 2013, DOI: 10.1002/hep.26179

  3. Milk thistle in liver diseases: past, present, future

    Phytotherapy Research

    Volume 24, Issue 10, October 2010, Pages: 1423–1432, Ludovico Abenavoli, Raffaele Capasso, Natasa Milic and Francesco Capasso

    Version of Record online : 7 JUN 2010, DOI: 10.1002/ptr.3207

  4. You have free access to this content
    Identifying the differential effects of silymarin constituents on cell growth and cell cycle regulatory molecules in human prostate cancer cells

    International Journal of Cancer

    Volume 123, Issue 1, 1 July 2008, Pages: 41–50, Gagan Deep, Nicholas H. Oberlies, David J. Kroll and Rajesh Agarwal

    Version of Record online : 8 APR 2008, DOI: 10.1002/ijc.23485

  5. Effects of Silymarin on Diabetes Mellitus Complications: A Review

    Phytotherapy Research

    Aline Maria Stolf, Cibele Campos Cardoso and Alexandra Acco

    Version of Record online : 25 JAN 2017, DOI: 10.1002/ptr.5768

  6. Effect of Silymarin Administration on Cisplatin Nephrotoxicity: Report from A Pilot, Randomized, Double-Blinded, Placebo-Controlled Clinical Trial

    Phytotherapy Research

    Volume 29, Issue 7, July 2015, Pages: 1046–1053, Foroud Shahbazi, Sanambar Sadighi, Simin Dashti-Khavidaki, Farhad Shahi, Mehrzad Mirzania, Alireza Abdollahi and Mohammad-Hossein Ghahremani

    Version of Record online : 7 APR 2015, DOI: 10.1002/ptr.5345

  7. Activities of silymarin and its flavonolignans upon low density lipoprotein oxidizability in vitro

    Phytotherapy Research

    Volume 13, Issue 6, September 1999, Pages: 535–537, N. Škottová, V. Krečman and V. Šimánek

    Version of Record online : 8 SEP 1999, DOI: 10.1002/(SICI)1099-1573(199909)13:6<535::AID-PTR526>3.0.CO;2-W

  8. You have free access to this content
    Multiple effects of silymarin on the hepatitis C virus lifecycle

    Hepatology

    Volume 51, Issue 6, June 2010, Pages: 1912–1921, Jessica Wagoner, Amina Negash, Olivia J. Kane, Laura E. Martinez, Yaakov Nahmias, Nigel Bourne, David M. Owen, Joe Grove, Claire Brimacombe, Jane A. McKeating, Eve-Isabelle Pécheur, Tyler N. Graf, Nicholas H. Oberlies, Volker Lohmann, Feng Cao, John E. Tavis and Stephen J. Polyak

    Version of Record online : 12 FEB 2010, DOI: 10.1002/hep.23587

  9. Stability-indicating HPTLC method for quantitative estimation of silybin in bulk drug and pharmaceutical dosage form

    Biomedical Chromatography

    Volume 24, Issue 6, June 2010, Pages: 639–647, Rabea Parveen, Sayeed Ahmad, Sanjula Baboota, Javed Ali and Ahuja Alka

    Version of Record online : 7 OCT 2009, DOI: 10.1002/bmc.1340

  10. Silymarin treatment of viral hepatitis: a systematic review

    Journal of Viral Hepatitis

    Volume 12, Issue 6, November 2005, Pages: 559–567, K. É. Mayer, R. P. Myers and S. S. Lee

    Version of Record online : 29 JUN 2005, DOI: 10.1111/j.1365-2893.2005.00636.x

  11. You have free access to this content
    Silymarin, a naturally occurring polyphenolic antioxidant flavonoid, inhibits azoxymethane-induced colon carcinogenesis in male F344 rats

    International Journal of Cancer

    Volume 101, Issue 5, 10 October 2002, Pages: 461–468, Hiroyuki Kohno, Takuji Tanaka, Kunihiro Kawabata, Yoshinobu Hirose, Shigeyuki Sugie, Hiroyuki Tsuda and Hideki Mori

    Version of Record online : 13 AUG 2002, DOI: 10.1002/ijc.10625

  12. Silybum marianum: non-medical exploitation of the species

    Annals of Applied Biology

    Volume 167, Issue 3, November 2015, Pages: 285–297, J. Andrzejewska, T. Martinelli and K. Sadowska

    Version of Record online : 18 JUN 2015, DOI: 10.1111/aab.12232

  13. Silymarin inhibits melanoma cell growth both in vitro and in vivo by targeting cell cycle regulators, angiogenic biomarkers and induction of apoptosis

    Molecular Carcinogenesis

    Volume 54, Issue 11, November 2015, Pages: 1328–1339, Mudit Vaid, Tripti Singh, Ram Prasad and Santosh K. Katiyar

    Version of Record online : 30 AUG 2014, DOI: 10.1002/mc.22208

  14. Effect of silymarin and silybinin on oxygen radicals

    Drug Development Research

    Volume 29, Issue 1, May 1993, Pages: 73–77, Carlos Pascual, Ricardo Gonz, Julio Armesto and Pablo Muriel

    Version of Record online : 5 OCT 2004, DOI: 10.1002/ddr.430290109

  15. A randomized double-blind, placebo-controlled study of therapeutic effects of silymarin in β-thalassemia major patients receiving desferrioxamine

    European Journal of Haematology

    Volume 90, Issue 3, March 2013, Pages: 202–209, Behjat Moayedi, Marjan Gharagozloo, Nafiseh Esmaeil, Mohammad R. Maracy, Hamid Hoorfar and Mohsen Jalaeikar

    Version of Record online : 20 JAN 2013, DOI: 10.1111/ejh.12061

  16. Milk thistle for alcoholic and/or hepatitis B or C virus liver diseases

    Intervention Review

    The Cochrane Library

    Andrea Rambaldi, Bradly P Jacobs and Christian Gluud

    Published Online : 17 OCT 2007, DOI: 10.1002/14651858.CD003620.pub3

  17. Significant inhibition by the flavonoid antioxidant silymarin against 12-O-tetradecanoylphorbol 13-acetate–caused modulation of antioxidant and inflammatory enzymes, and cyclooxygenase 2 and interleukin-1α expression in SENCAR mouse epidermis: Implications in the prevention of stage I tumor promotion

    Molecular Carcinogenesis

    Volume 26, Issue 4, December 1999, Pages: 321–333, Jifu Zhao, Yogesh Sharma and Rajesh Agarwal

    Version of Record online : 22 NOV 1999, DOI: 10.1002/(SICI)1098-2744(199912)26:4<321::AID-MC11>3.0.CO;2-9

  18. Batch solvent extraction of flavanolignans from milk thistle (Silybum marianum L. Gaertner)

    Phytochemical Analysis

    Volume 16, Issue 1, January/February 2005, Pages: 7–16, Sunny N. Wallace, Danielle J. Carrier and Edgar C. Clausen

    Version of Record online : 24 JAN 2005, DOI: 10.1002/pca.803

  19. You have free access to this content
    Neuroprotective Potential of Silymarin against CNS Disorders: Insight into the Pathways and Molecular Mechanisms of Action

    CNS Neuroscience & Therapeutics

    Volume 19, Issue 11, November 2013, Pages: 847–853, Anupom Borah, Rajib Paul, Sabanum Choudhury, Amarendranath Choudhury, Bornalee Bhuyan, Anupam Das Talukdar, Manabendra Dutta Choudhury and Kochupurackal P Mohanakumar

    Version of Record online : 14 OCT 2013, DOI: 10.1111/cns.12175

  20. Preparation and effects of 2,3-dehydrosilymarin, a promising and potent antioxidant and free radical scavenger

    Journal of Pharmacy and Pharmacology

    Volume 63, Issue 2, February 2011, Pages: 238–244, Shanshan Tong, Chang Chu, Yuan Wei, Li Wang, Xizhe Gao, Ximing Xu and Jiangnan Yu

    Version of Record online : 18 NOV 2010, DOI: 10.1111/j.2042-7158.2010.01210.x